Inventor · disambiguated record
Alexander James Bridges
Also filed as: BRIDGES ALEXANDER J · BRIDGES ALEXANDER JAMES · BRIDGES Alexander
45 granted patents·21 pending applications·4,644 citations·filing 1986–2025
99Inventor score
Files withWARNER LAMBERT CO32ONL THERAPEUTICS INC8BIOMARIN PHARM INC5CS PHARMATECH LTD2KERSCHEN JAMES ALAN2
Top patents by PatentIndex Score
66 records- 0199US6562818B1Irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 2000·Granted May 13, 2003·139 cites·19 claims
- 0299US6127374AIrreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 1998·Granted Oct 3, 2000·183 cites·16 claims
- 0398US6713484B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2002·Granted Mar 30, 2004·291 cites·8 claims
- 0498US6602863B1Irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 2000·Granted Aug 5, 2003·236 cites·23 claims
- 0598US6521620B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Feb 18, 2003·295 cites·8 claims
- 0698US6455534B2Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 2001·Granted Sep 24, 2002·274 cites·18 claims
- 0798US6344459B1Irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 1997·Granted Feb 5, 2002·367 cites·17 claims
- 0898US6310060B12-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 1998·Granted Oct 30, 2001·146 cites·37 claims
- 0998US5654307ABicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Aug 5, 1997·479 cites·2 claims
- 1097US7169816B24-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2005·Granted Jan 30, 2007·30 cites·16 claims
- 1197US6821963B24-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Nov 23, 2004·52 cites·21 claims
- 1297US6265410B1Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1998·Granted Jul 24, 2001·306 cites·45 claims
- 1397US6153617AIrreversible bicyclic inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 1998·Granted Nov 28, 2000·112 cites·22 claims
- 1497US6084095ASubstituted pyrido[3,2-d]pyrimidines capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 4, 2000·292 cites·2 claims
- 1597US5679683ATricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1994·Granted Oct 21, 1997·306 cites·2 claims
- 1696US6596726B1Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor familyWARNER LAMBERT CO·Filed 1997·Granted Jul 22, 2003·232 cites·10 claims
- 1796US6469004B1Benzoheterocycles and their uses as MEK inhibitorsWARNER LAMBERT CO·Filed 2000·Granted Oct 22, 2002·134 cites·44 claims
- 1896US5525625A2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disordersWARNER LAMBERT CO·Filed 1995·Granted Jun 11, 1996·200 cites·8 claims
- 1993US7019033B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2002·Granted Mar 28, 2006·26 cites·11 claims
- 2093US6344455B1N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, and irreversible inhibitor of tyrosine kinasesWARNER LAMBERT CO·Filed 1999·Granted Feb 5, 2002·213 cites·15 claims
- 2190US7030119B1Method for treating chronic pain using MEK inhibitorsWARNER LAMBERT CO·Filed 2000·Granted Apr 18, 2006·45 cites·28 claims
- 2288US10508134B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2016·Granted Dec 17, 2019·4 cites·24 claims
- 2388US6545030B11-heterocycle substituted diarylaminesWARNER LAMBERT CO·Filed 1999·Granted Apr 8, 2003·78 cites·42 claims
- 2487US6492363B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2001·Granted Dec 10, 2002·14 cites·35 claims
- 2586US4780468A8-trifluoromethyl quinolones as antibacterial agentsWARNER LAMBERT CO·Filed 1987·Granted Oct 25, 1988·40 cites·18 claims
- 2684US10829518B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2019·Granted Nov 10, 2020·2 cites·22 claims
- 2780US12258425B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·4 claims
- 2878US10227323B2Glucosylceramide synthase inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2014·Granted Mar 12, 2019·3 cites·21 claims
- 2975US8809526B2Synthesis of cyclopentaquinazolinesKERSCHEN JAMES ALAN·Filed 2011·Granted Aug 19, 2014·2 cites·66 claims
- 3075US7786131B2Pyrimido[5,4-d]pyrimidines derivatives as irreversible inhibitors of tyrosine kinasesWARNER LAMBERT CO·Filed 2003·Granted Aug 31, 2010·6 cites·8 claims
- 3175US4755594AN6 -substituted adenosinesWARNER LAMBERT CO·Filed 1986·Granted Jul 5, 1988·26 cites·26 claims
- 3275US2025099554A1Compositions and methods of fas inhibitionONL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3373US2025346631A1Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3472US6696440B1Treatment of asthma with MEK inhibitorsWARNER LAMBERT CO·Filed 1999·Granted Feb 24, 2004·34 cites·13 claims
- 3572US4803205AQuinolones as antibacterial agentsWARNER LAMBERT CO·Filed 1988·Granted Feb 7, 1989·9 cites·11 claims
- 3671US9458188B2Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline trisodium saltKERSCHEN JAMES ALAN·Filed 2011·Granted Oct 4, 2016·2 cites·20 claims
- 3771US4962194AMethod of preparing 51,N6-disubstituted adenosines from inosinesWARNER LAMBERT CO·Filed 1988·Granted Oct 9, 1990·17 cites·5 claims
- 3870US11597749B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2020·Granted Mar 7, 2023·0 cites·16 claims
- 3968US7067538B2MCP-1 receptor antagonists and methods of use thereofWARNER LAMBERT CO·Filed 2003·Granted Jun 27, 2006·4 cites·15 claims
- 4066US10308608B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2018·Granted Jun 4, 2019·0 cites·14 claims
- 4164US5340833AUrokinase inhibitorsEISAI CO LTD·Filed 1992·Granted Aug 23, 1994·22 cites·15 claims
- 4264US2021009519A1Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2020·Application pending·0 cites
- 4363US2025312350A1Inhibitors of rlip76AVESTA76 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4462US10927092B2Glucosylceramide synthase inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2019·Granted Feb 23, 2021·0 cites·14 claims
- 4561US4933335AQuinolones as antibacterial agentsWARNER LAMBERT CO·Filed 1988·Granted Jun 12, 1990·5 cites·5 claims
- 4659US10851058B2Histone deacetylase inhibitorsBIOMARIN PHARM INC·Filed 2016·Granted Dec 1, 2020·0 cites·18 claims
- 4758US6251943B1Method of treating or preventing septic shock by administering a MEK inhibitorWARNER LAMBERT CO·Filed 1997·Granted Jun 26, 2001·18 cites·9 claims
- 4856US2021260168A1Compositions and methods of fas inhibitionONL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4954US2005049429A14-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsFiled 2004·Application pending·0 cites
- 5053US2008312239A1Methods for the treatment of erectile dysfunction using fispemifeneQUATRX PHARMACEUTICALS COMPANY·Filed 2008·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →